KAYLA THOMASON: Open Payments
NPI 1942828090 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,172 in 109 payments from 21 companies in 2025. Trend: 2023 $1,538 · 2024 $1,296 · 2025 $2,172
Food & beverage: $2,172
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 15 | $288 |
| PFIZER INC. | 15 | $240 |
| Novartis Pharmaceuticals Corporation | 10 | $233 |
| Novo Nordisk Inc | 14 | $233 |
| ABBVIE INC. | 10 | $187 |
| AstraZeneca Pharmaceuticals LP | 5 | $184 |
| Edwards Lifesciences Corporation | 5 | $155 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $143 |
| Otsuka America Pharmaceutical, Inc. | 7 | $139 |
| Dexcom, Inc. | 3 | $68 |
Products named: LEQVIO, Kerendia, REXULTI, BREZTRI, ZEPBOUND, NURTEC ODT, SAPIEN 3 Ultra RESILIA, Ozempic.
Industry payments across SC — which companies pay providers there.
